Understanding how mRNA methylation affects heart development after birth
Official title: Mettl14 mediated mRNA methylation orchestrates postnatal cardiac development
Funded at University of Pittsburgh at Pittsburgh · NIH-10950644 · Data updated 2026-11-12
This study is looking at how certain changes in genetic material affect heart development right after birth, with the hope of finding new ways to help heal heart injuries.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | August 26, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $119,250 |
| NIH project number | 1R03HL174881-01 |
| Project ID | NIH-10950644 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are infants and young children with congenital heart defects or cardiac injuries, as well as adults with heart conditions seeking innovative therapies.
✕Less likely to help
Patients with chronic heart disease unrelated to developmental issues or those who are not in the early stages of cardiac injury may not benefit from this research.
What this research studies
This research investigates the role of mRNA methylation in the development of the heart during the early postnatal period. By studying how specific molecular mechanisms influence the heart's ability to regenerate, the research aims to uncover insights that could lead to improved therapies for heart injuries. The approach involves advanced sequencing techniques to analyze the regulation of gene expression during heart development, focusing on the methyltransferase complex that modifies mRNA. This could provide a better understanding of how to harness regenerative capabilities in cardiac therapies.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance heart regeneration after injury, significantly improving outcomes for patients with heart conditions.
How similar studies have gone: Other research has shown promising results in understanding cardiac regeneration through similar molecular approaches, indicating potential for success in this area.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Zhang, Manling — University of Pittsburgh at Pittsburgh
- Study coordinator: Zhang, Manling
Related research
Other NIH-funded projects on the same topics.
-
Elastomeric membranes for safer pelvic organ prolapse repair
A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.
-
Role of hyaluronan in egg development and ovarian reserve
This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.
-
Regulatory switches that control imprinting in early human development
This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.
-
Identifying molecular signs of imprinting errors linked to fertility treatments
This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.
-
Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy
A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.
-
Spermatogonial stem cell transplantation and culture in patients
Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.